AlphaCrest Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-72,489
| Closed | -$1.91M | – | 1450 |
|
|
2021
Q4 | $1.91M | Buy |
72,489
+67,508
| +1,355% | +$1.78M | 0.07% | 453 |
|
|
2021
Q3 | $501K | Buy |
4,981
+69
| +1% | +$6.94K | 0.03% | 903 |
|
|
2021
Q2 | $695K | Sell |
4,912
-4,488
| -48% | -$635K | 0.03% | 827 |
|
|
2021
Q1 | $937K | Buy |
9,400
+7,700
| +453% | +$768K | 0.05% | 526 |
|
|
2020
Q4 | $210K | Buy |
+1,700
| New | +$210K | 0.02% | 1067 |
|
|
2020
Q2 | – | Sell |
-2,500
| Closed | -$361K | – | 1175 |
|
|
2020
Q1 | $361K | Buy |
+2,500
| New | +$361K | 0.04% | 713 |
|